SchizophreniaArchives
The Economic Impact of Cumulative Metabolic Comorbidity Burden in Schizophrenia: A Claims-Based Analysis of Medical Costs in the United States
Schizophrenia 1 min.
Metabolic comorbidities, including central adiposity, dyslipidemia, insulin resistance, and hypertension, are common in individuals with schizophrenia and contribute to an increased risk of cardiovascular disease and related mortality. There is limited evidence quantifying the economic burden of metabolic...
Barriers to long-acting injectable antipsychotic use for community-dwelling patients with schizophrenia in China: a qualitative process analysis
Schizophrenia 1 min.
Long-acting injectable antipsychotics (LAIs) have proven more effective for treating patients with schizophrenia than oral formulations. However, the use of LAIs in China remains low and this phenomenon is still under-researched. This study endeavors to provide a better understanding by systematically...
Quality of life between schizophrenia patients and family caregivers in Northern China: an actor-partner interdependence mediation model of stigma and social support
Schizophrenia 1 min.
Schizophrenia poses significant challenges to the lives of individuals and to society. However, limited research has explored the relationship between stigma and quality of life in both patients with schizophrenia and their family caregivers. Furthermore, the potential mediating role of social support...
Driver or passenger? A new assessment of genes in the schizophrenia-associated 3q29 deletion locus for contribution to neurodevelopmental disorders
Schizophrenia 1 min.
3q29 deletion (3q29Del) syndrome is caused by a 1.6 Mb copy number variant (CNV) located near the telomeric end of the long arm of the third human chromosome. Hemizygosity of this set of 22 protein-coding genes significantly increases risk for schizophrenia and autism spectrum disorders among other neurodevelopmental...
